Peptoid Tat/transactivation response element inhibitor, inhibiting human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry

Novel HIV-1 protease inhibitor, also potently inhibiting major aspartyl peptidase 1 (May1), a secreted Cryptococcus neoformans protease

Activator of RORalpha, inducing growth arrest in androgen-independent DU 145 prostate cancer cells

Non-peptide tachykinin NK1 receptor antagonist

Novel inhibitor of Wnt/β-catenin signaling; Anticancer agent promoting PKCα-mediated β-catenin phosphorylation/degradation

Novel Bruton's tyrosine kinase (BTK) inhibitor

Novel functional Gboxin analogue that is suitable for live-cell ultraviolet crosslink conjugation and click chemistry

Novel PRL-3 inhibitor, blocking the migration and invasion of metastatic cancer cells

Novel inducer of neural differentiation and growth arrest in human primary GBM-derived cells, playing a tumor-suppressive role via cAMP/CREB signaling pathway

Novel GSK3 inhibitor, inducing cell death through cyclin D1 depletion in breast cancer cells

Novel Highly Potent, Selective, Bioavailable TTK (threonine tyrosine kinase) Inhibitor

Potent inhibitor of TTK kinase

Novel non-steroid reversible dual inhibitor of CYP17 and CYP11B2 against prostate cancer with fewer cardiac side effects

Novel Probe for the High Temperature Requirement A (HTRA) Serine Proteases

Novel probe for cellulose synthase trafficking, inhibiting cellulose deposition and interferes with the trafficking of cellulose synthase complexes and their associated proteins KORRIGAN1 and POM2/CSI1

Novel small molecule prodrug for use with SEAKER cells, exhibiting enhanced anticancer activity

Natural disrupter of RNA G-quadruplexes, inhibiting G-quadruplex-dependent alternative splicing, stimulting the stomach lining and inducing vomiting

Novel selective inhibitor of the nuclear enzymes poly(ADP-ribose) polymerase (PARP) 1 and 2

Novel potent, selective, and orally bioavailable inverse agonist of the histamine H 3 receptor (H 3 R)

Prodrug of CEP-751 (KT-6587) as antitumor agent, inhibiting protein kinases

Novel potent ALK inhibitor

Novel potent ALK inhibitor. also inhibiting the insulin receptor

Novel highly selective TAF1 inhibitor

Novel modulator of cell death signal transduction pathways, reducing the cytotoxicity of anthrax lethal toxin (LT)

Broad-spectrum, fifth-generation cephalosporin antibiotic, inactivating penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall

beta-Lactamase-stable, broad-spectrum, third-generation cephalosporin antibiotic with antibacterial activity

Broad-spectrum fourth-generation cephalosporin antibiotic

Fourth-generation cephalosporin

Third-generation broad spectrum antibiotic against both gram-positive and gram-negative microorganisms

Broad-spectrum, beta-lactamase-resistant, second-generation cephalosporin antibiotic, inhibiting bacterial cell wall synthesis via inhibition of cross-linking of peptidoglycans